Robert Kimberly, MD
Director, UAB Center for Clinical and Translational Science
Senior Associate Dean for Clinical and Translational Research
Associate Vice President for Medicine and Biomedical Research
r kimberly contact

Administrative Staff

 
Jennifer Croker, PhD
Executive Administrator, Research Commons

Questions about research resources and programs? Information about scheduling a project panel?
jennifer
Jean Lambert, MA
Investigator Liaison
Want to know more about training opportunities, mentoring resources, seminars or career development resources?
jean composite
Angela Schmeckebier 
Program Director, Research Commons
Need to schedule a Panel Done Quickly (PDQ)? Questions about our Research Voucher Program?
Angie2 cropped

Ryan Outman, MS
Administrative Director, CCTS Training Academy
Want to know more about training, mentoring resources, seminars or career development resources?

ryan outman web
Jamye Hester
Administrative Assistant

Would you like to reserve the PCAMS building for an event or meeting?
jamye
Andria M. Cimino, MPH
Director of Strategic Communications & Outreach
Do you have a CTS success story to share? Feedback concerning our communication efforts? Questions about our website or social media channels?
a cimino3
Kate Matthews
Web Communications Specialist 
Questions about our website or social media channels?
Kate Matthews
Brian Wallace
Director of Visual Communications
Do you need help creating and implementing a visual message? Do you need guidance sharing your message digitally or in person?
b wallace web
Richard Hines, MBA
Director, Finance

Financial questions?
richard hines

Clinical Translation Contacts

Clinical Trials Program
Mansoor Saleh, MD
Medical Director, UAB Clinical Trials Administration Office
Director, CCTS/CCC Phase I Clinical Trial Unit 
205-996-1403 or 205-934-2248 / mns@uab.edu

Professor of Medicine and Pathology / Scientist, UAB Comprehensive Cancer Center/ Associate Director, Clinical Trials Network / Chair, Clinical Trials Review Committee
mansoor saleh cto2
Dr. Saleh, an experienced clinical trialist, works closely with investigators in the development of protocols, industry relationships and continuing enhancement of operational excellence in the conduct of our clinical trials. Implementing training and continuing education for investigators in good clinical practice and current trends in clinical trials, Dr. Saleh is a champion for excellence and a strong voice for the investigators in all disciplines.

Contact Dr. Saleh and his team for more information regarding the PHASE I CLINICAL TRIAL UNIT. 

Clinical Research Support and Training (CRSP)
Penelope Jester, RN, MPH, CCRC
Co-Director, UAB Clinical Trials Office
205-934-2424 / pjester@uab.edu
penny jester headshot web









Meredith Fitz-Gerald, RN, MSN
Research Nurse Manager 
UAB Clinical Trials Office
UAB Clinical Research Support Program
205-975-2758 / mfitzgerald@uabmc.edu
meredith sized web
CRSP provides trained coordinators and research nurses to investigative teams that need additional assistance with study implementation ranging from regulatory assistance to study performance and close-out. CRSP provides staffing flexibility to investigators and enables the training of all study team personnel. 


Facilitation of Administrative Processes and Multi-site Trials
Jason Nichols, OD, MPH, PhD, FAAO
Assistant Vice President, Industry Research Development
205-934-5109 / jjn@uab.edu

Dr. Nichols is facilitating our clinical trials portfolio by improving administrative processes and by developing new and expanded relationships with the pharmaceutical industry. Through the CCTS, he is also facilitating the development of multi-site trials by connecting investigators and assisting with administrative arrangements.

Jason nichols web2

Investigational New Drug / Investigational Device Exemptions
Maaike Everts, PhD
Associate Professor, Pediatric Infectious Diseases; 
Co-Director, Academic Drug Discovery Alliance
205-934-2973 / maaike@uab.edu

Dr. Everts leads a team that is available to advise investigators on FDA application processes for Investigational New Drugs (IND) and Investigative Device Exemptions (IDE). She can also assist in the translation of locally identified druggable targets into drug screening and development pipelines for novel compounds.
maaike everts web2